CID 657356

Diacylglycerol kinase inhibitor ii

Structural Information

Molecular Formula
C28H25F2N3OS
SMILES
C1CN(CCC1=C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CCN4C(=O)C5=CC=CC=C5NC4=S
InChI
InChI=1S/C28H25F2N3OS/c29-22-9-5-19(6-10-22)26(20-7-11-23(30)12-8-20)21-13-15-32(16-14-21)17-18-33-27(34)24-3-1-2-4-25(24)31-28(33)35/h1-12H,13-18H2,(H,31,35)
InChIKey
ZCNBZFRECRPCKU-UHFFFAOYSA-N
Compound name
3-[2-[4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

63
References

536
Patents

489.16864 Da
Monoisotopic Mass

5.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 490.17592 215.7
[M+Na]+ 512.15786 230.5
[M+NH4]+ 507.20246 221.3
[M+K]+ 528.13180 218.8
[M-H]- 488.16136 220.1
[M+Na-2H]- 510.14331 223.5
[M]+ 489.16809 219.5
[M]- 489.16919 219.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe